跳至主要内容
临床试验/NCT00899587
NCT00899587Unknown1 期

Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家开始时间: 2009年5月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
试验地点
1

研究概览

简要总结

In this study, patients were divided into 3 group with 35 cases including: 1.oxygen 2.enalapril 3.control.

In the beginning of the study, best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), and optical coherence tomography (OCT) were measured. Patients in the oxygen group were given oxygen 10 lit/min 1 hour twice a day at the first month, once a day at the second month and every other day at the third month. In the enalapril group, patients were given enalapril 5 mg every night and placebo was given for the patients in third group. At the end of first month the patients' vision was checked again and at the the end of the third month the first physical examinations were performed. In the first group, arterial blood gas (ABG) was taken before and after oxygen therapy as well.

研究设计

研究类型
Interventional

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with diabetic macular ischemia

排除标准

  • HTN > 1140/90 or HTN controlled by ACE inhibitors
  • FBS > 200
  • Severe anemia, COPD, cataract, HRPDR and diffuse macular edema

研究组 & 干预措施

Oxygen

Experimental

干预措施: oxygen (Other)

Enalapril

Experimental

干预措施: enalapril (Drug)

Control

Placebo Comparator

干预措施: placebo (Drug)

研究者

研究点 (1)

Loading locations...

相似试验